NCT03520114

Brief Summary

One in five women will undergo prolapse surgery in their lifetime, and there is a strong correlation between prolapse and urinary incontinence. Pelvic floor surgeons aspire to improve relevant quality of life outcomes for women with pelvic floor disorders while minimizing complications and unnecessary procedures. There has been an experience of disappointment and frustration when a patient returns following POP repair with new symptoms of Stress Urinary Incontinence (SUI) that she ranks as a greater disruption to her quality of life than her original vaginal bulge. While retropubic (RP) slings are considered to be the "gold-standard" referent for other slings with long-term outcomes data, they are associated with the highest risks of intra- and post-operative complications including bladder injury, bleeding, and post-operative voiding dysfunction. Single-incision slings (SIS) are the latest iteration in sling development that build upon the benefits of slings but avoid passage through the muscles of the inner thigh. The hypothesis for this study is that single-incision slings (Altis) are non-inferior to Retropubic mid-urethral slings when placed at the time of native tissue vaginal repair.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 9, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

December 12, 2018

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2024

Completed
1 year until next milestone

Results Posted

Study results publicly available

January 16, 2025

Completed
Last Updated

January 16, 2025

Status Verified

September 1, 2023

Enrollment Period

5.1 years

First QC Date

April 26, 2018

Results QC Date

November 22, 2024

Last Update Submit

January 14, 2025

Conditions

Keywords

Retropubic slingSingle-incision slingVaginal repairManagement

Outcome Measures

Primary Outcomes (5)

  • Number of Participants With Subjectively Bothersome Stress Incontinence

    Dichotomous outcome (Yes/No), measured by a positive response of \> 1 to Question 17 on Pelvic Floor Distress Inventory short form-20 (PFDI-20). Response scale from 0 to 4. Symptoms Not Present = NO 0 = not present Symptoms Present = YES, scale of bother: 1 = not at all, 2 = somewhat, 3 = moderately, 4 = quite a bit

    12 months post-operatively

  • Count of Participants Needing Retreatment for Stress Incontinence

    This includes pelvic floor physical therapy; incontinence pessary; urethral bulking injection; repeat incontinence surgery.

    12 months post-operatively

  • Count of Participants With De Novo or Worsening Urge Incontinence Symptoms

    Dichotomous outcome (Yes/No), measured by a worsening change in response to Question 16 on PFDI-20 with at least somewhat bothersome symptoms. Response scale from 0 to 4. Symptoms Not Present = NO 0 = not present Symptoms Present = YES, scale of bother: 1 = not at all, 2 = somewhat, 3 = moderately, 4 = quite a bit

    12 months post-operatively

  • Count of Participants Requiring Bladder Drainage

    Beyond 2 weeks post-operatively with PVR \> 150 ml OR \> 1/3 total voided volume up to 12 Month post-operatively..

    12 Month post-operatively

  • Count of Participants Needing Surgical Intervention for Urinary Retention

    Sling lysis or revision at any time point post-operatively up to 12 Month post-operatively.

    12 Month post-operatively

Secondary Outcomes (2)

  • Number of Participants With Adverse Events

    12 months post-operatively

  • Surgeon Satisfaction Scores

    post-operatively up to 12 months

Study Arms (2)

RP sling group

EXPERIMENTAL

Participants assigned to the retropubic (RP) sling group will have the RP sling placement procedure.

Device: RP sling placement

SIS group

EXPERIMENTAL

Participants assigned to the single-incision sling (SIS) group will have the SIS placement procedure.

Device: SIS placement

Interventions

A 1.5 cm incision will be made at the mid-urethra through a separate vaginal incision with lateral dissection with Metzembaum scissors. After placement of both trocars, cystoscopy with a 70-degree scope will be performed to assess for bladder and urethral injury. Surgeons will set the tension of the tension-free vaginal tape (TVT) slings so that a spacer can be placed between the sling and the urethra. Sling tensioning will be performed after anterior and apical prolapse is corrected.

RP sling group

The sling is introduced through a single anterior vaginal incision of 1.5 cm at the mid-urethra. The sling/needle assembly is advanced behind the ischiopubic rami in a transobturator trajectory toward the obturator space bilaterally. The needle is then removed by simply sliding the fixating tip back out. The other side is then completed in an identical fashion. After the fixation of the two anchors at the 2 and 10 o'clock positions, the patient's bladder is filled with 250 mL of Sodium Chloride (NaCl). Afterward, an intraoperative crede maneuver is performed and the tension adjustment suture is pulled, when necessary, to achieve the desired continence. The mesh will lie in direct apposition to the urethra. The adjustment thread is then cut short and the vaginal incision is closed with an absorbable suture.

SIS group

Eligibility Criteria

Age21 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 21 years of age
  • Women being considered for a native tissue vaginal repair in any vaginal compartment or colpocleisis
  • POP ≥ stage II of any vaginal compartment, according to the pelvic organ prolapse quantification (POP-Q) system
  • Vaginal bulge symptoms
  • Positive standardized cough stress test on clinical examination, or on urodynamic testing
  • Surgical plan that includes a native tissue vaginal repair including colpocleisis for symptomatic POP in any compartment
  • Understanding and acceptance of the need to return for all scheduled follow-up visits
  • English speaking and able to give informed consent
  • Willing and able to complete all study questionnaires

You may not qualify if:

  • Prior surgery for stress urinary incontinence
  • Status post reconstructive pelvic surgery with transvaginal mesh kits or sacrocolpopexy with synthetic mesh for prolapse
  • Any serious disease, or chronic condition, that could interfere with the study compliance
  • Unwilling to have a synthetic sling
  • Inability to give informed consent
  • Pregnancy or planning pregnancy in the first postoperative year
  • Untreated urinary tract infection (may be included after resolution)
  • Poorly-controlled diabetes mellitus (HgbA1c \> 9 within 3 months of surgery date)
  • Prior pelvic radiation
  • Incarcerated
  • Neurogenic bladder/ pre-operative self-catheterization
  • Elevated post-void residual (\>150 ml) that does not resolve with prolapse reduction testing (pessary, prolapse reduced uroflow or micturition study)
  • Prior augmented (synthetic mesh, autologous graft, xenograft, allograft) prolapse repair
  • Planned concomitant bowel related surgery including sphincteroplasty and perineal rectal prolapse surgery, rectovaginal fistula repair, hemorrhoidectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

MedStar Health/National Center for Advance Pelvic Surgery

Washington D.C., District of Columbia, 20010, United States

Location

Northwestern Medical Group

Chicago, Illinois, 60611, United States

Location

Northwell Health

Manhasset, New York, 11030, United States

Location

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, 27157, United States

Location

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02903, United States

Location

Related Publications (3)

  • Mezes CM, Russell GB, Gutman RE, Iglesia C, Rardin C, Kenton K, Collins S, Matthews CA. Effect of Vaginal Prolapse Repair and Midurethral Sling on Urgency Incontinence Symptoms. Urogynecology (Phila). 2025 Mar 1;31(3):250-257. doi: 10.1097/SPV.0000000000001620. Epub 2024 Dec 13.

  • Matthews CA, Rardin CR, Sokol A, Iglesia C, Collins S, Ferrando C, Winkler H, Kenton K, Geynisman-Tan J, Gutman RE. A randomized trial of retropubic vs single-incision sling among patients undergoing vaginal prolapse repair. Am J Obstet Gynecol. 2024 Aug;231(2):261.e1-261.e10. doi: 10.1016/j.ajog.2024.04.036. Epub 2024 May 3.

  • Carter E, Johnson EE, Still M, Al-Assaf AS, Bryant A, Aluko P, Jeffery ST, Nambiar A. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2023 Oct 27;10(10):CD008709. doi: 10.1002/14651858.CD008709.pub4.

MeSH Terms

Conditions

Urinary Incontinence, StressPelvic Floor Disorders

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPregnancy Complications

Results Point of Contact

Title
Sachin Nalin Vyas, MS,PhD
Organization
Wake Forest University

Study Officials

  • Catherine Matthews, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants and will be masked during the one-year follow-up period.Precautions will be taken to minimize unmasking the study groups: Since RP slings require two suprapubic stab incisions, identical sham incision will also be performed in the SIS group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2018

First Posted

May 9, 2018

Study Start

December 12, 2018

Primary Completion

January 2, 2024

Study Completion

January 2, 2024

Last Updated

January 16, 2025

Results First Posted

January 16, 2025

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations